J. Clin. Med. 2013, 2(4), 176-187; doi:10.3390/jcm2040176
Review

Bone Targeted Therapies for Bone Metastasis in Breast Cancer

email
Received: 18 July 2013; in revised form: 7 August 2013 / Accepted: 10 September 2013 / Published: 14 October 2013
(This article belongs to the Special Issue Prevention and Treatment of Bone Metastases from Breast Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Cancer metastasis to the bone develops commonly in patients with various malignancies, and is a major cause of morbidity and diminished quality of life in many affected patients. Emerging treatments for metastatic bone disease have arisen from advances in our understanding of the unique cellular and molecular mechanisms that contribute to the bone metastasis. The tendency of cancer cells to metastasize to bone is probably the end result of many factors including vascular pathways, the highly vascular nature of the bone marrow (which increases the probability that cancer cells will be deposited in bone marrow capillaries), and molecular characteristics of the cancer cells that allow them to adapt to the bone marrow microenvironment. The goals of treating osseous metastases are manifold. Proper treatment can lead to significant improvements in pain control and function, and maintain skeletal integrity. The treatment plan requires a multidisciplinary approach. Widespread metastatic disease necessitates systemic therapy, while a localized problem is best managed with surgery, external beam radiotherapy, or both. Patients with bone metastasis can have prolonged survival, and proper management can have a significant impact on their quality of life. We will review the factors in this article that are promising molecular bone-targeted therapies or will be likely targets for future therapeutic intervention to restore bone remodeling and suppress tumor growth.
Keywords: bone metastasis; bisphosphonates; bone-targeted therapy; radiopharmaceuticals
PDF Full-text Download PDF Full-Text [220 KB, uploaded 14 October 2013 16:19 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Razaq, W. Bone Targeted Therapies for Bone Metastasis in Breast Cancer. J. Clin. Med. 2013, 2, 176-187.

AMA Style

Razaq W. Bone Targeted Therapies for Bone Metastasis in Breast Cancer. Journal of Clinical Medicine. 2013; 2(4):176-187.

Chicago/Turabian Style

Razaq, Wajeeha. 2013. "Bone Targeted Therapies for Bone Metastasis in Breast Cancer." J. Clin. Med. 2, no. 4: 176-187.

J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert